The "Synchron CX3 System" (Beckman Instruments, Inc., Brea, CA 92621) measures Cl with a two-phase Ag/ AgC1 ion-selective electrode USE). The Cl result is calculated from the difference, SR, between the ADC (digital form of analog signal) numbers for electrolyte reference reagent (Cl = 100 mxnollL), IR, and for a sample, S; i.e., SR = S -IR. According to the manufacturer, Br in concentrations of 1.0 and 3.0 mniol/L increases the results for apparent Cl by 3% and 6%, respectively. We determined that repeat analysis of "Gilford Normal" (GN) control serum (Ciba Corning Diagnostic Corp., Irving, CA 92714), subsequently found to contain 1.1 mmol of Br per liter, adversely affected the precision of Cl measurements and caused intermittent "excessive reference drift" (ERD) error codes. Therefore, we measured Cl, sequentially, in aliquots (n s15) of GN control and Br-free control sample supplemented with Br (0.2-2.0 mmolJL). We monitored the ISE response by recording the ADC numbers.
The cumulative interference pattern for GN control and Br samples was the same (Figure 1 ). In general, the repeat analysis of aliquots caused gradual increases in both ADC numbers, the extent of which depended on the concentration of Br, and which, when large enough, caused ERD error. Except for the first aliquot of each sequence, the stepwise increments tended to be greater for S; i.e., the SR values and, therefore, the results for Cl were affected, the changes being significant when Br was 0.8 mmol/L, and there was also a significant carryover effect on Br-free samples (Figure 1 ). The ISE was normalized only by a repeat analysis of a Br-free sample. There was no interference or carryover effect when, in sequence, Br-containing aliquots were separated by at least one Br-free aliquot. However, analysis of a random sample with Br 2.5 mmolJL caused ERD error.
We conclude that Br 2.0 mmol/L does not affect Cl measurements unless repeated analysis is attempted, as would be in case in troubleshooting the method. We also suggest that all control materials intended for use with the CX3 should be tested for such cumulative interference. We used a reaction time of6 mAnrather than 15 mm as described for the kit assay, because bile acid concentrations ofseruin specimens changed <1% with this decrease in reaction time.
As Figure 1 shows, standards must be ofthe same matrix as samples for accurate results. When cholic acid standards were prepared in de-ionized water or in 60 g/L bovine serum albumin reagent, the slope of the standard curve (sensitivity) was decreased from that for the Enzabile standards, which are lyophilized in a bovine serum matrix. Preparing the standards in a normal serum pool with negligible bile acid not only increased the sensitivity but also produced a line essentially the same as that obtained with Enzabile standards. This is consistent with the findings ofQureshi et al. (2) , who noted that bovine and human serums contain a factor that enhances the reaction. This factor is probably not protein, as evidenced by the lack of enhancement of the standard line prepared in bovine serum albumin. Contrary to the manufacturer's suggestion of making dilutions (up to four times) with isotonic saline, we dilute serum and bile fluid (regardless of dilution) with a fourfold dilution in saline of normal serum selected to contain little or no bile acid. This diluting solution maintains the serum enhancement factor at an optimal concentration. Bile fluids may also be diluted with saline, if aqueous standards are used.
Within-run precision (CV) for determinations of serum pools with normal and above normal bile acid concentrations were 4.3% (mean 5.6 molIL, SD 0.24 /LmoIIL, n = 24) and 1.2% (mean 35.6 1moIJL, SD 0.44 imoIJL, n 25). The CV for 21 replicate inter-run determinations performed over 11 days was 5.1% (mean 37.5 mol/L, SD 1.91 p.mol/L).
Bile acid values determined with the kit (y) for 44 serum and bile specimens ranging in concentration from 2 to 320 ;Lmol/L, with Enzabile standards in bovine serum matrix, correlated well with those obtained by an enzymic-fluorometric method (x) with aqueous cholic acid standards (3, 4) : We have developed a simple, rapid, and convenient staining method for detecting phospholipids on thin-layer chromatograms of amniotic fluid (AF) by modifying Zinzade's reagent, originally used in the determination of phosphorus (1, 2) .
After centrifuging 5-niL aliquots ofAF for 5 mm at 600 x g to remove cellular debris, we extract the lipids from the supernatant fluid and precipitate the phospholipids with cold acetone.
Extracts and standards in chloroform are streaked onto thin-layer chromatographic plates (plastic sheets, silica gel 60, no. 5748; Merck, Darmstadt, F.R.G.), previously activated (100 #{176}C, 30 mm) and allowed to cool in a desiccator. We use the solvent system chloroformimethanollanunomum hydroxide (580 milL), 5/30/3 by vol, for one-dimensional chromatography (3). After developing the plates, we dry them in hot air until the odor of ammonia is no longer detectable, then leave them at 37 #{176}C for 5 mm, let them cool, and immerse them for about 5 5 in staining solution. The staining solution (2) is prepared just before use by diluting fourfold with water the following reagent: To a solution of 10 g of sodium molybdate in 60 mL of 4 molIL HC1, add 14 mL of 4 molJL HC1 containing 400 mg of hydrazinium chloride. Heat in a boiling water-bath for 20 mm, cool, then add 14 mL of concentrated sulfuric acid and mix, with cooling. Adjust the volume to 100 mL with water, and store in a dark bottle at room temperature.
After the staining, we dry the chromatogram in a current of cold air (to prevent development of background color) until blue spots become visible.
We quanti1r the phospholipids either densitometrically or by visual comparison with the spots produced by solutions of phospholipids of known concentration.
We have successfully used this procedure in assessing normal and high-risk pregnancies.
Advantages of this method as compared with commonly used methods for staining phospholipids in AF are: high reagent stability (the stock reagent shows no deterioration for more than six months); lower acid content; good sensitivity; and high contrast between spots and background
